Grantham, Mayo, Van Otterloo & Co (GMO)’s Oak Street Health, Inc. OSH Stock Holding History

Grantham, Mayo, Van Otterloo & Co (GMO)’s Portfolio OSH Stock Details OSH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-263,304	Closed	-$10.2M	–	768
2023 Q1	$10.2M	Buy	+263,304	New	+$8.5M	0.05%	247

Other funds holding OSH

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Comerica Bank Dallas, Texas $25.1B AUM 24.68% 1-Year Est. Return

Grantham, Mayo, Van Otterloo & Co (GMO)'s OSH Position: Q2 2023 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) sold out of Oak Street Health, Inc. (OSH) in Q2 2023, closing a stake of 263,304 shares — an estimated $10.2M sold.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in OSH in Q1 2023 and held it in 1 quarter. The position peaked at $10.2M in Q1 2023. 3 funds tracked by Wall St. Rank hold OSH as of Q2 2023.

Grantham, Mayo, Van Otterloo & Co (GMO) reported no remaining Oak Street Health, Inc. position as of Q2 2023 after selling out during the quarter.
Grantham, Mayo, Van Otterloo & Co (GMO) sold 263,304 Oak Street Health, Inc. shares in Q2 2023, an estimated $10.2M.
Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Oak Street Health, Inc. in Q1 2023 and held it in 1 quarter.
Grantham, Mayo, Van Otterloo & Co (GMO)'s Oak Street Health, Inc. position peaked at $10.2M in Q1 2023.
3 funds tracked by Wall St. Rank held Oak Street Health, Inc. as of Q2 2023.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q2 2023, filed 14 Aug 2023.